Orbimed Advisors LLC Immatics N.V. Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Orbimed Advisors LLC holds 2,006,381 shares of IMTX stock, worth $23.5 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
2,006,381
Previous 1,769,708
13.37%
Holding current value
$23.5 Million
Previous $18.6 Million
25.35%
% of portfolio
0.56%
Previous 0.42%
Shares
6 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
76.6MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$117 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$112 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$94.9 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$87.2 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$75.6 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $894M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...